Table 2.
Rivaroxaban | Apixaban | Betrixaban | Edoxaban | |
---|---|---|---|---|
Bioavailability | > 80% | > 50% | ~ 35% | > 80% |
Onset of action, hrs | 2–4 | ~ 3 | 1–3 | 1–2 |
Half-life, hrs | 5–13 | 9–14 | ~ 20 | 8–10 |
Metabolism | 1/3 renal; 2/3 liver (CYP 450) | Multiple pathways (25% renal) | Via bile (~ 5% renal) | Multiple (majority renal) |
Likehood of drug interactions | Low–Mod | Low | Low | Low-Mod |
Dosing | Oral once daily | Oral twice daily | Oral once daily | Oral once daily |